Seven Months Postpartum With a 'Slightly High' A1c: Prediabetes or a Missed Diagnosis?
A 34-year-old woman, G2P2, is 7 months postpartum after a pregnancy complicated by gestational diabetes that required insulin from 32 weeks. She is breastfeeding, teaches high school, and has a BMI of 32 kg/m². Her mother and older sister both have type 2 diabetes. At a well-child visit she mentions fatigue and asks, 'They said my sugar was a little high at my checkup - do I have diabetes now?' Records show a 6-month postpartum A1c of 5.9% and, drawn the same morning, a fasting plasma glucose of 106 mg/dL. She never completed the recommended postpartum oral glucose tolerance test. She wants to know whether she can 'just wait until next year' to deal with it.
1. Interpret the A1c and fasting glucose. What is her current glycemic category, and is there anything else you would obtain before settling on a plan?
Read the worked answer
Both values fall in the prediabetes range, and they agree with each other.
- A1c 5.7–6.4% = prediabetes; hers is 5.9%.
- Fasting plasma glucose 100–125 mg/dL = impaired fasting glucose; hers is 106 mg/dL.
- Neither meets diabetes criteria (A1c ≥6.5%, FPG ≥126, 2-h OGTT ≥200, or random ≥200 with symptoms).
But 'prediabetes' understates her risk. A history of gestational diabetes requiring insulin carries a markedly elevated lifetime risk of type 2 diabetes - roughly half to two-thirds of such women develop it, with the steepest incidence in the first 5 years. She also has BMI 32 and a strong first-degree family history.
Before finalizing the plan, obtain:
- A 75-g oral glucose tolerance test. She never had one, and A1c can miss isolated post-load hyperglycemia, which is common in prior GDM. If the 2-hour value is ≥140 mg/dL, that confirms impaired glucose tolerance and strengthens the case for intensive prevention.
- Confirm there is no anemia or recent blood loss that would distort the A1c - fatigue is nonspecific, but a hemoglobin/ferritin would also address the possibility that a falsely low A1c is masking higher glycemia.
- A symptom review for polyuria/polydipsia and, if any are present, immediate diagnostic testing rather than a screening interval.
Absent those findings, this is prediabetes with high progression risk - not a diagnosis that can safely be parked for a year.
2. She asks whether she should start metformin. How do you weigh lifestyle intervention against metformin for this specific patient, and what do you recommend?
Read the worked answer
Lifestyle first, with metformin held in reserve - and explain why in numbers she can act on.
Weighing the options:
- Lifestyle (7% weight loss plus ~150 min/week of moderate activity) reduced progression to diabetes by ~58% in the Diabetes Prevention Program, and by more in older participants. It also addresses the hypertension, lipids, and sleep she has not yet been screened for.
- Metformin reduced progression by ~31% in the same trial. Guidelines suggest considering it for prediabetes when BMI is ≥35, age <60, or there is a history of gestational diabetes. She meets the GDM criterion and is under 60, so metformin is defensible - it is not wrong, it is just second-line.
What tips the decision toward lifestyle now:
- She is breastfeeding. Metformin is generally considered compatible with lactation, so this is not a hard contraindication, but a modest calorie deficit plus increased activity is the intervention with the best evidence and no medication burden.
- A 7% loss from her current weight is ~6–7 kg - a concrete, achievable target. A deficit of ~500 kcal/day producing 0.5 kg/week is compatible with breastfeeding if she keeps intake adequate (roughly ≥1800 kcal/day and adequate protein, iron, and calcium). Aggressive crash dieting is not, and risks milk supply and fatigue.
- Set a checkpoint: if she has not lost ~2–3% of body weight or her A1c is rising at 3–6 months, metformin becomes the reasonable next step.
Frame it as a choice she makes, not a test she can fail.
3. What follow-up and screening plan do you propose, and which findings would make you escalate to active treatment or earlier retesting?
Read the worked answer
Build the plan around her actual risk trajectory, not a generic 'annual' stamp.
Proposed schedule:
- Now: 75-g OGTT, CBC/ferritin, lipids, blood pressure, and a conversation about future pregnancy plans (recurrence risk in a subsequent pregnancy is high, and preconception A1c matters).
- 3 months: weight and a focused behavioral check-in. Do not repeat A1c this soon - at 5.9% the change is within assay noise and adds cost without changing management.
- Annually, at minimum: A1c or FPG. Many guidelines advise every 1–3 years depending on other risk features; given prior GDM, insulin requirement in pregnancy, BMI 32, and family history, she sits at the frequent end of that range. Lifelong screening applies - the risk does not expire.
- Before any future pregnancy: early screening and preconception counseling.
Escalate sooner if:
- Symptoms of hyperglycemia develop (then test immediately, regardless of schedule).
- A1c reaches ≥6.0–6.2% or FPG rises above 115–120 mg/dL on repeat - a rising trajectory is more informative than a single value.
- The OGTT shows a 2-hour value ≥140 mg/dL, particularly ≥160, which would justify metformin plus structured lifestyle referral.
- She cannot access affordable food or time for activity - screen for food insecurity and social constraints at each visit, because a prevention plan she cannot execute is not a plan.
Reinforce that the postpartum period is a window of unusually high motivation: she has just demonstrated she can manage a complex regimen, and that competence transfers.